Tell your friends about this item:
Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine J Morganroth Softcover reprint of the original 1st ed. 1989 edition
Risk / Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents: Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988 - Developments in Cardiovascular Medicine
J Morganroth
The Ninth Annual symposium on New Drugs addressed the problem of determining the risk versus benefit for use of three important classes of cardiovascular agents: thrombolytic, antiarrhythmic, and hypolipidemic agents.
298 pages, biography
| Media | Books Paperback Book (Book with soft cover and glued back) |
| Released | October 10, 2011 |
| ISBN13 | 9781461288886 |
| Publishers | Springer-Verlag New York Inc. |
| Pages | 298 |
| Dimensions | 234 × 154 × 23 mm · 490 g |
| Language | English |
| Editor | Moore, E. Neil |
| Editor | Morganroth, J. |
More by J Morganroth
Show allMere med samme udgiver
See all of J Morganroth ( e.g. Paperback Book )